GO:0003676 | nucleic acid binding | 13.94% (29/208) | 2.18 | 0.0 | 0.0 |
GO:0005488 | binding | 33.17% (69/208) | 1.05 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 48.08% (100/208) | 0.76 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 22.6% (47/208) | 1.27 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 22.6% (47/208) | 1.27 | 0.0 | 0.0 |
GO:0032555 | purine ribonucleotide binding | 11.54% (24/208) | 1.89 | 0.0 | 1e-06 |
GO:0035639 | purine ribonucleoside triphosphate binding | 11.54% (24/208) | 1.89 | 0.0 | 1e-06 |
GO:0017076 | purine nucleotide binding | 11.54% (24/208) | 1.84 | 0.0 | 2e-06 |
GO:0097367 | carbohydrate derivative binding | 11.54% (24/208) | 1.8 | 0.0 | 3e-06 |
GO:0034641 | cellular nitrogen compound metabolic process | 10.58% (22/208) | 1.9 | 0.0 | 3e-06 |
GO:0032553 | ribonucleotide binding | 11.54% (24/208) | 1.81 | 0.0 | 3e-06 |
GO:0005575 | cellular_component | 17.31% (36/208) | 1.39 | 0.0 | 3e-06 |
GO:0046483 | heterocycle metabolic process | 9.13% (19/208) | 1.98 | 0.0 | 8e-06 |
GO:0006725 | cellular aromatic compound metabolic process | 9.13% (19/208) | 1.98 | 0.0 | 8e-06 |
GO:0006139 | nucleobase-containing compound metabolic process | 8.65% (18/208) | 2.03 | 0.0 | 8e-06 |
GO:1901360 | organic cyclic compound metabolic process | 9.13% (19/208) | 1.95 | 0.0 | 9e-06 |
GO:0032991 | protein-containing complex | 7.21% (15/208) | 2.24 | 1e-06 | 1.2e-05 |
GO:0032559 | adenyl ribonucleotide binding | 9.13% (19/208) | 1.71 | 5e-06 | 9.4e-05 |
GO:0030554 | adenyl nucleotide binding | 9.13% (19/208) | 1.71 | 5e-06 | 9.4e-05 |
GO:0005524 | ATP binding | 9.13% (19/208) | 1.71 | 5e-06 | 9.4e-05 |
GO:0000166 | nucleotide binding | 12.02% (25/208) | 1.42 | 6e-06 | 9.9e-05 |
GO:1901265 | nucleoside phosphate binding | 12.02% (25/208) | 1.42 | 6e-06 | 9.9e-05 |
GO:0008144 | drug binding | 9.62% (20/208) | 1.64 | 6e-06 | 0.0001 |
GO:0090304 | nucleic acid metabolic process | 7.21% (15/208) | 1.97 | 5e-06 | 0.000101 |
GO:0036094 | small molecule binding | 12.5% (26/208) | 1.37 | 7e-06 | 0.000115 |
GO:0005643 | nuclear pore | 1.92% (4/208) | 4.53 | 1e-05 | 0.000146 |
GO:0043168 | anion binding | 12.02% (25/208) | 1.35 | 1.4e-05 | 0.000204 |
GO:0016072 | rRNA metabolic process | 1.44% (3/208) | 5.11 | 2.4e-05 | 0.00032 |
GO:0006364 | rRNA processing | 1.44% (3/208) | 5.11 | 2.4e-05 | 0.00032 |
GO:0016070 | RNA metabolic process | 5.77% (12/208) | 2.02 | 3.4e-05 | 0.000443 |
GO:0017144 | drug metabolic process | 1.92% (4/208) | 4.11 | 4.3e-05 | 0.000528 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 1.92% (4/208) | 4.11 | 4.3e-05 | 0.000528 |
GO:0016779 | nucleotidyltransferase activity | 2.4% (5/208) | 3.53 | 4.6e-05 | 0.000539 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 5.77% (12/208) | 1.97 | 5e-05 | 0.000575 |
GO:0034062 | 5'-3' RNA polymerase activity | 1.92% (4/208) | 3.94 | 7.6e-05 | 0.000826 |
GO:0097747 | RNA polymerase activity | 1.92% (4/208) | 3.94 | 7.6e-05 | 0.000826 |
GO:0009058 | biosynthetic process | 7.69% (16/208) | 1.54 | 0.000114 | 0.001195 |
GO:0098796 | membrane protein complex | 2.88% (6/208) | 2.89 | 0.00012 | 0.001233 |
GO:0005198 | structural molecule activity | 3.85% (8/208) | 2.38 | 0.000124 | 0.001234 |
GO:0009987 | cellular process | 18.75% (39/208) | 0.84 | 0.000195 | 0.001893 |
GO:0018130 | heterocycle biosynthetic process | 4.33% (9/208) | 2.09 | 0.000232 | 0.001921 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 4.33% (9/208) | 2.11 | 0.000209 | 0.001933 |
GO:0044237 | cellular metabolic process | 12.5% (26/208) | 1.07 | 0.00023 | 0.001941 |
GO:1901576 | organic substance biosynthetic process | 6.73% (14/208) | 1.6 | 0.000205 | 0.001946 |
GO:0006396 | RNA processing | 2.88% (6/208) | 2.74 | 0.000219 | 0.00198 |
GO:0006807 | nitrogen compound metabolic process | 12.02% (25/208) | 1.1 | 0.000229 | 0.001982 |
GO:0017056 | structural constituent of nuclear pore | 1.44% (3/208) | 4.37 | 0.000228 | 0.00202 |
GO:0019438 | aromatic compound biosynthetic process | 4.33% (9/208) | 2.07 | 0.000258 | 0.002089 |
GO:0044249 | cellular biosynthetic process | 6.73% (14/208) | 1.56 | 0.000266 | 0.002109 |
GO:0046907 | intracellular transport | 2.88% (6/208) | 2.65 | 0.000314 | 0.002441 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0015986 | ATP synthesis coupled proton transport | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0006754 | ATP biosynthetic process | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0015985 | energy coupled proton transport, down electrochemical gradient | 1.44% (3/208) | 4.11 | 0.000447 | 0.00245 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 3.85% (8/208) | 2.18 | 0.000337 | 0.002572 |
GO:1901362 | organic cyclic compound biosynthetic process | 4.33% (9/208) | 2.01 | 0.000349 | 0.002611 |
GO:0051649 | establishment of localization in cell | 2.88% (6/208) | 2.61 | 0.000372 | 0.002729 |
GO:0032550 | purine ribonucleoside binding | 2.4% (5/208) | 2.91 | 0.000424 | 0.002749 |
GO:0032561 | guanyl ribonucleotide binding | 2.4% (5/208) | 2.91 | 0.000424 | 0.002749 |
GO:0032549 | ribonucleoside binding | 2.4% (5/208) | 2.91 | 0.000424 | 0.002749 |
GO:0001882 | nucleoside binding | 2.4% (5/208) | 2.91 | 0.000424 | 0.002749 |
GO:0005525 | GTP binding | 2.4% (5/208) | 2.91 | 0.000424 | 0.002749 |
GO:0001883 | purine nucleoside binding | 2.4% (5/208) | 2.91 | 0.000424 | 0.002749 |
GO:0090407 | organophosphate biosynthetic process | 2.4% (5/208) | 2.91 | 0.000424 | 0.002749 |
GO:0051641 | cellular localization | 2.88% (6/208) | 2.57 | 0.000438 | 0.002794 |
GO:0017111 | nucleoside-triphosphatase activity | 3.85% (8/208) | 2.07 | 0.000581 | 0.00314 |
GO:0046390 | ribose phosphate biosynthetic process | 1.44% (3/208) | 3.89 | 0.000766 | 0.003771 |
GO:0009260 | ribonucleotide biosynthetic process | 1.44% (3/208) | 3.89 | 0.000766 | 0.003771 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.44% (3/208) | 3.89 | 0.000766 | 0.003771 |
GO:0072522 | purine-containing compound biosynthetic process | 1.44% (3/208) | 3.89 | 0.000766 | 0.003771 |
GO:0030117 | membrane coat | 1.44% (3/208) | 3.89 | 0.000766 | 0.003771 |
GO:0006164 | purine nucleotide biosynthetic process | 1.44% (3/208) | 3.89 | 0.000766 | 0.003771 |
GO:0046034 | ATP metabolic process | 1.44% (3/208) | 3.89 | 0.000766 | 0.003771 |
GO:0032040 | small-subunit processome | 0.96% (2/208) | 5.11 | 0.000833 | 0.003902 |
GO:0030684 | preribosome | 0.96% (2/208) | 5.11 | 0.000833 | 0.003902 |
GO:1905354 | exoribonuclease complex | 0.96% (2/208) | 5.11 | 0.000833 | 0.003902 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.85% (8/208) | 1.98 | 0.000865 | 0.00396 |
GO:0016462 | pyrophosphatase activity | 3.85% (8/208) | 1.98 | 0.000865 | 0.00396 |
GO:0043170 | macromolecule metabolic process | 10.58% (22/208) | 1.06 | 0.000817 | 0.003973 |
GO:0006886 | intracellular protein transport | 2.4% (5/208) | 2.68 | 0.000926 | 0.004188 |
GO:0034645 | cellular macromolecule biosynthetic process | 4.33% (9/208) | 1.81 | 0.00102 | 0.004561 |
GO:0009141 | nucleoside triphosphate metabolic process | 1.44% (3/208) | 3.7 | 0.001199 | 0.004963 |
GO:0009150 | purine ribonucleotide metabolic process | 1.44% (3/208) | 3.7 | 0.001199 | 0.004963 |
GO:0019693 | ribose phosphate metabolic process | 1.44% (3/208) | 3.7 | 0.001199 | 0.004963 |
GO:0006163 | purine nucleotide metabolic process | 1.44% (3/208) | 3.7 | 0.001199 | 0.004963 |
GO:0009259 | ribonucleotide metabolic process | 1.44% (3/208) | 3.7 | 0.001199 | 0.004963 |
GO:0072521 | purine-containing compound metabolic process | 1.44% (3/208) | 3.7 | 0.001199 | 0.004963 |
GO:1902600 | proton transmembrane transport | 1.44% (3/208) | 3.7 | 0.001199 | 0.004963 |
GO:0110165 | cellular anatomical entity | 10.58% (22/208) | 1.01 | 0.001293 | 0.005297 |
GO:0042886 | amide transport | 2.4% (5/208) | 2.53 | 0.001523 | 0.005925 |
GO:0015833 | peptide transport | 2.4% (5/208) | 2.53 | 0.001523 | 0.005925 |
GO:0015031 | protein transport | 2.4% (5/208) | 2.53 | 0.001523 | 0.005925 |
GO:0045184 | establishment of protein localization | 2.4% (5/208) | 2.53 | 0.001523 | 0.005925 |
GO:0019001 | guanyl nucleotide binding | 2.4% (5/208) | 2.53 | 0.001523 | 0.005925 |
GO:0033036 | macromolecule localization | 2.4% (5/208) | 2.48 | 0.001774 | 0.006765 |
GO:0008104 | protein localization | 2.4% (5/208) | 2.48 | 0.001774 | 0.006765 |
GO:0071704 | organic substance metabolic process | 13.94% (29/208) | 0.81 | 0.00187 | 0.007063 |
GO:0071705 | nitrogen compound transport | 2.4% (5/208) | 2.39 | 0.002365 | 0.008677 |
GO:0071702 | organic substance transport | 2.4% (5/208) | 2.39 | 0.002365 | 0.008677 |
GO:1901566 | organonitrogen compound biosynthetic process | 3.37% (7/208) | 1.92 | 0.002348 | 0.008782 |
GO:0009059 | macromolecule biosynthetic process | 4.33% (9/208) | 1.62 | 0.002487 | 0.009042 |
GO:0044238 | primary metabolic process | 12.98% (27/208) | 0.8 | 0.003105 | 0.011081 |
GO:0019637 | organophosphate metabolic process | 2.4% (5/208) | 2.3 | 0.003086 | 0.011117 |
GO:0034470 | ncRNA processing | 1.44% (3/208) | 3.24 | 0.003313 | 0.011406 |
GO:0009165 | nucleotide biosynthetic process | 1.44% (3/208) | 3.24 | 0.003313 | 0.011406 |
GO:1901293 | nucleoside phosphate biosynthetic process | 1.44% (3/208) | 3.24 | 0.003313 | 0.011406 |
GO:0015672 | monovalent inorganic cation transport | 1.44% (3/208) | 3.24 | 0.003313 | 0.011406 |
GO:0043167 | ion binding | 13.94% (29/208) | 0.74 | 0.00398 | 0.013232 |
GO:0097659 | nucleic acid-templated transcription | 2.4% (5/208) | 2.22 | 0.003955 | 0.013263 |
GO:0006351 | transcription, DNA-templated | 2.4% (5/208) | 2.22 | 0.003955 | 0.013263 |
GO:0003924 | GTPase activity | 1.92% (4/208) | 2.59 | 0.003907 | 0.013331 |
GO:0098655 | cation transmembrane transport | 1.44% (3/208) | 3.11 | 0.004324 | 0.013788 |
GO:0009117 | nucleotide metabolic process | 1.44% (3/208) | 3.11 | 0.004324 | 0.013788 |
GO:0015078 | proton transmembrane transporter activity | 1.44% (3/208) | 3.11 | 0.004324 | 0.013788 |
GO:0098662 | inorganic cation transmembrane transport | 1.44% (3/208) | 3.11 | 0.004324 | 0.013788 |
GO:0098660 | inorganic ion transmembrane transport | 1.44% (3/208) | 3.11 | 0.004324 | 0.013788 |
GO:0007005 | mitochondrion organization | 0.96% (2/208) | 4.11 | 0.004806 | 0.014957 |
GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o) | 0.96% (2/208) | 4.11 | 0.004806 | 0.014957 |
GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) | 0.96% (2/208) | 4.11 | 0.004806 | 0.014957 |
GO:0034220 | ion transmembrane transport | 1.44% (3/208) | 3.0 | 0.005503 | 0.016989 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 1.44% (3/208) | 2.89 | 0.006856 | 0.020836 |
GO:0006753 | nucleoside phosphate metabolic process | 1.44% (3/208) | 2.89 | 0.006856 | 0.020836 |
GO:0030120 | vesicle coat | 0.96% (2/208) | 3.79 | 0.007858 | 0.023697 |
GO:0003677 | DNA binding | 3.37% (7/208) | 1.6 | 0.008148 | 0.024381 |
GO:1901137 | carbohydrate derivative biosynthetic process | 1.44% (3/208) | 2.79 | 0.00839 | 0.024724 |
GO:0015077 | monovalent inorganic cation transmembrane transporter activity | 1.44% (3/208) | 2.79 | 0.00839 | 0.024724 |
GO:0043228 | non-membrane-bounded organelle | 2.4% (5/208) | 1.94 | 0.009202 | 0.026714 |
GO:0043232 | intracellular non-membrane-bounded organelle | 2.4% (5/208) | 1.94 | 0.009202 | 0.026714 |
GO:0043226 | organelle | 3.85% (8/208) | 1.43 | 0.009694 | 0.027728 |
GO:0043229 | intracellular organelle | 3.85% (8/208) | 1.43 | 0.009694 | 0.027728 |
GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain | 0.96% (2/208) | 3.53 | 0.011564 | 0.032597 |
GO:0098800 | inner mitochondrial membrane protein complex | 0.96% (2/208) | 3.53 | 0.011564 | 0.032597 |
GO:0032774 | RNA biosynthetic process | 2.4% (5/208) | 1.85 | 0.012031 | 0.033428 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.44% (3/208) | 2.61 | 0.012017 | 0.03363 |
GO:0016740 | transferase activity | 6.25% (13/208) | 1.01 | 0.012421 | 0.034268 |
GO:0044260 | cellular macromolecule metabolic process | 6.73% (14/208) | 0.94 | 0.014282 | 0.039126 |
GO:0008324 | cation transmembrane transporter activity | 1.92% (4/208) | 2.02 | 0.015983 | 0.043478 |
GO:0005515 | protein binding | 9.13% (19/208) | 0.75 | 0.017496 | 0.047263 |
GO:0006812 | cation transport | 1.92% (4/208) | 1.98 | 0.017647 | 0.047342 |